...
机译:低密度脂蛋白受体相关蛋白5的T253I突变引起常染色体显性I型骨质疏松症患者的破骨细胞在体外是正常的,但体内吸收能力降低
From Pharmos Bioscience,Nordic Bioscience and Center for Clinical and Basic Research A/S, Herlev, Denmark;
Ribe County Hospital,Esbjerg, Denmark;
From Pharmos Bioscience,Nordic Bioscience and Center for Clinical and Basic Research A/S, Herlev, Denmark;
and the Section of Medical Endocrinology,Research Institute, National University Hospital, Oslo, Norway;
and the Department of Medicine,Research Institute, National University Hospital, Oslo, Norway;
Hovedstadens Sygehusf?llesskab Blodbank,The University Hospital of Copenhagen, Copenhagen, Denmark;
From Pharmos Bioscience,Nordic Bioscience and Center for Clinical and Basic Research A/S, Herlev, Denmark;
and the Section of Medical Endocrinology,Research Institute, National University Hospital, Oslo, Norway;
From Pharmos Bioscience,Nordic Bioscience and Center for Clinical and Basic Research A/S, Herlev, Denmark;
机译:CLCN7的新型突变导致中国患者常染色体显性遗传骨质疏松症II型(ADO-II)和中度常染色体隐性骨质疏松症(IARO)
机译:新型CLCN7突变引起常染色体显性骨质障碍症II型和中间常染色体隐性骨质棘刺症
机译:常染色体显性高骨质量的新解释:低密度脂蛋白受体相关蛋白6的突变
机译:低密度脂蛋白受体相关蛋白5的T253I突变引起常染色体显性I型骨质疏松症患者的破骨细胞在体外是正常的但体内吸收能力降低
机译:低密度脂蛋白受体相关蛋白5的T253I突变引起常染色体显性I型骨质疏松症患者的破骨细胞在体外是正常的,但体内吸收能力降低